142 related articles for article (PubMed ID: 31665501)
1. Viral antigens elicit augmented immune responses in primary Sjögren's syndrome.
Björk A; Thorlacius GE; Mofors J; Richardsdotter Andersson E; Ivanchenko M; Tingström J; James T; Brokstad KA; Cox RJ; Jonsson R; Kvarnström M; Wahren-Herlenius M
Rheumatology (Oxford); 2020 Jul; 59(7):1651-1661. PubMed ID: 31665501
[TBL] [Abstract][Full Text] [Related]
2. H1N1 vaccination in Sjögren's syndrome triggers polyclonal B cell activation and promotes autoantibody production.
Brauner S; Folkersen L; Kvarnström M; Meisgen S; Petersen S; Franzén-Malmros M; Mofors J; Brokstad KA; Klareskog L; Jonsson R; Westerberg LS; Trollmo C; Malmström V; Ambrosi A; Kuchroo VK; Nordmark G; Wahren-Herlenius M
Ann Rheum Dis; 2017 Oct; 76(10):1755-1763. PubMed ID: 28760805
[TBL] [Abstract][Full Text] [Related]
3. EBV reactivation serological profile in primary Sjögren's syndrome: an underlying trigger of active articular involvement?
Pasoto SG; Natalino RR; Chakkour HP; Viana Vdos S; Bueno C; Leon EP; Vendramini MB; Neto ML; Bonfa E
Rheumatol Int; 2013 May; 33(5):1149-57. PubMed ID: 22955798
[TBL] [Abstract][Full Text] [Related]
4. Immune responses after influenza vaccination in patients of primary Sjögren's syndrome.
Zhou X; Liu Y; Jin Y; Wang Y; Miao M; Chen J; Cheng Y; Liu Y; He J; Li Z
Rheumatology (Oxford); 2021 Jan; 60(1):224-230. PubMed ID: 32671409
[TBL] [Abstract][Full Text] [Related]
5. Autoantibody to MDM2: A potential serological marker of primary Sjogren's syndrome.
Liu Y; Liao X; Wang Y; Chen S; Sun Y; Lin Q; Shi G
Oncotarget; 2017 Feb; 8(9):14306-14313. PubMed ID: 28147328
[TBL] [Abstract][Full Text] [Related]
6. Interferon activation status underlies higher antibody response to viral antigens in patients with systemic lupus erythematosus receiving no or light treatment.
Björk A; Da Silva Rodrigues R; Richardsdotter Andersson E; Ramírez Sepúlveda JI; Mofors J; Kvarnström M; Oke V; Svenungsson E; Gunnarsson I; Wahren-Herlenius M
Rheumatology (Oxford); 2021 Mar; 60(3):1445-1455. PubMed ID: 33006609
[TBL] [Abstract][Full Text] [Related]
7. Treatment of primary Sjögren's syndrome with hydroxychloroquine.
Fox RI; Chan E; Benton L; Fong S; Friedlaender M; Howell FV
Am J Med; 1988 Oct; 85(4A):62-7. PubMed ID: 3177432
[TBL] [Abstract][Full Text] [Related]
8. Discrepancy of Serological and Molecular Patterns of Circulating Epstein-Barr Virus Reactivation in Primary Sjögren's Syndrome.
Sanosyan A; Daien C; Nutz A; Bollore K; Bedin AS; Morel J; Zimmermann V; Nocturne G; Peries M; Guigue N; Gottenberg JE; Van de Perre P; Mariette X; Tuaillon E
Front Immunol; 2019; 10():1153. PubMed ID: 31191532
[TBL] [Abstract][Full Text] [Related]
9. Circulating small non-coding RNAs reflect IFN status and B cell hyperactivity in patients with primary Sjögren's syndrome.
Lopes AP; Hillen MR; Chouri E; Blokland SLM; Bekker CPJ; Kruize AA; Rossato M; van Roon JAG; Radstake TRDJ
PLoS One; 2018; 13(2):e0193157. PubMed ID: 29447268
[TBL] [Abstract][Full Text] [Related]
10. Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren's syndrome adults from a defined population.
Akiyama M; Sasaki T; Kaneko Y; Yasuoka H; Suzuki K; Yamaoka K; Takeuchi T
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):157-164. PubMed ID: 29465360
[TBL] [Abstract][Full Text] [Related]
11. A re-evaluation of anti-NA-14 antibodies in patients with primary Sjögren's syndrome: Significant role of interferon-γ in the production of autoantibodies against NA-14.
Uomori K; Nozawa K; Ikeda K; Doe K; Yamada Y; Yamaguchi A; Fujishiro M; Kawasaki M; Morimoto S; Takamori K; Sekigawa I; Chan EK; Takasaki Y
Autoimmunity; 2016 Aug; 49(5):347-56. PubMed ID: 27328271
[TBL] [Abstract][Full Text] [Related]
12. Effect of Chinese herbal medicine for nourishing yin, supplementing qi, and activating blood on the Th1/Th2 immune balance in peripheral blood in patients with primary Sjogren's syndrome.
Wu GL; Li TY; Fan YS; Yu GY; Chen J
Chin J Integr Med; 2013 Sep; 19(9):696-700. PubMed ID: 23975134
[TBL] [Abstract][Full Text] [Related]
13. Clinical and immunological characteristics of patients with Sjögren's syndrome in relation to alpha-fodrin antibodies.
Willeke P; Gaubitz M; Schotte H; Becker H; Mickholz E; Domschke W; Schlüter B
Rheumatology (Oxford); 2007 Mar; 46(3):479-83. PubMed ID: 16935916
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies in primary Sjögren's syndrome patients induce internalization of muscarinic type 3 receptors.
Jin M; Hwang SM; Davies AJ; Shin Y; Bae JS; Lee JH; Lee EB; Song YW; Park K
Biochim Biophys Acta; 2012 Feb; 1822(2):161-7. PubMed ID: 22137887
[TBL] [Abstract][Full Text] [Related]
15. Increased Interleukin-17F is Associated with Elevated Autoantibody Levels and More Clinically Relevant Than Interleukin-17A in Primary Sjögren's Syndrome.
Gan Y; Zhao X; He J; Liu X; Li Y; Sun X; Li Z
J Immunol Res; 2017; 2017():4768408. PubMed ID: 28210632
[TBL] [Abstract][Full Text] [Related]
16. Complement inhibitor C4b-binding protein in primary Sjögren's syndrome and its association with other disease markers.
Zadura AF; Theander E; Blom AM; Trouw LA
Scand J Immunol; 2009 Apr; 69(4):374-80. PubMed ID: 19284503
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression.
Brkic Z; Maria NI; van Helden-Meeuwsen CG; van de Merwe JP; van Daele PL; Dalm VA; Wildenberg ME; Beumer W; Drexhage HA; Versnel MA
Ann Rheum Dis; 2013 May; 72(5):728-35. PubMed ID: 22736090
[TBL] [Abstract][Full Text] [Related]
18. Association of BAFF and IL-17A with subphenotypes of primary Sjögren's syndrome.
Deng F; Chen J; Zheng J; Chen Y; Huang R; Yin J; Gao X; Lin Q; Huang C; Gao Y; Yu X; Liu Z
Int J Rheum Dis; 2016 Jul; 19(7):715-20. PubMed ID: 25941062
[TBL] [Abstract][Full Text] [Related]
19. Polyarthritis in primary Sjögren's syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up.
ter Borg EJ; Kelder JC
Clin Rheumatol; 2016 Mar; 35(3):649-55. PubMed ID: 26791875
[TBL] [Abstract][Full Text] [Related]
20. Altered phenotype and Stat1 expression in Toll-like receptor 7/8 stimulated monocyte-derived dendritic cells from patients with primary Sjögren's syndrome.
Vogelsang P; Karlsen M; Brun JG; Jonsson R; Appel S
Arthritis Res Ther; 2014 Aug; 16(4):R166. PubMed ID: 25113744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]